New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
18:05 EDTZTSZoetis could climb 25%, Barron's says
Zoetis (ZTS) isn't subject to the same patent expiration cliff as Pfizer (PFE) and earnings should rise 13% over the next few years, Barron's says in its "Weekday Trader" column. Shares could climb 25%, the paper adds. Reference Link
News For ZTS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent ZTS news | >>
November 20, 2014
05:32 EDTZTSZoetis downgraded to Market Perform from Outperform at William Blair
Subscribe for More Information
November 19, 2014
08:19 EDTZTSZoetis price target raised to $55 from $45 at Guggenheim
Subscribe for More Information
06:56 EDTZTSZoetis price target raised to $48 from $41 at JPMorgan
Subscribe for More Information
06:39 EDTZTSZoetis price target raised to $50 from $43 at Piper Jaffray
Subscribe for More Information
November 18, 2014
18:15 EDTZTSAckman urges significant cost cuts at Zoetis, Bloomberg says
Subscribe for More Information
13:45 EDTZTSZoetis trading resumes, shares down 61c to $43.62
Subscribe for More Information
13:44 EDTZTSZoetis sees 'modest improvements' in gross margin ahead of 2017
Subscribe for More Information
13:43 EDTZTSZoetis sees 2016, 2017 net income growth 11%-16%
Subscribe for More Information
13:42 EDTZTSZoetis sees net income growth in low double-digits over long term
Zoetis said it believes it can grow adjusted net income in the low double-digits over the long term.
13:38 EDTZTSZoetis sees FY15 adjusted EPS $1.61-$1.68, consensus $1.71
Subscribe for More Information
13:32 EDTZTSZoetis trading halted, pending news
Subscribe for More Information
07:55 EDTZTSZoetis price target raised to $50 from $41 at Argus
Argus increased its price target on Zoetis after Bill Ackman's firm disclosed that it had acquired an 8.5% stake in the company. The firm thinks that Ackman may search for a potential buyer of Zoetis. Argus also believes that the company's margins can rise, and it keeps a Buy rating on the shares.
07:00 EDTZTSZoetis announces authorization of $500M share repurchase program
Subscribe for More Information
06:49 EDTZTSValeant likely to pursue more moderate-sized deals, says Piper Jaffray
Subscribe for More Information
November 17, 2014
10:40 EDTZTSZoetis to host investor day
Subscribe for More Information
08:16 EDTZTSZoetis to purchase assets of Abbott Animal Health for about $255M
Subscribe for More Information
08:15 EDTZTSZoetis to purchase assets of Abbott Animal Health for about $255M
November 14, 2014
17:14 EDTZTSPershing Square gives quarterly update on stakes
Subscribe for More Information
17:11 EDTZTSZoetis adopts poison pill to protect company from potential hostile takeover
Subscribe for More Information
10:25 EDTZTSOptions with increasing implied volatility: BHI DWA ZTS
Subscribe for More Information
1 | 2 | all recent ZTS news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use